Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion.

ABSTRACT:

Purpose

To investigate the association of retinal thickness 1 month after the first study aflibercept or bevacizumab injection with later retinal thickness, visual acuity, and number of treatments in eyes enrolled in the Study of COmparative Treatments for REtinal Vein Occlusion 2.

Design

Cohort study using data from a randomized clinical trial.

Methods

Analysis included one eye from each of 350 participants through 2 years of follow-up. Main outcome measures were central subfield thickness (CST), best-corrected visual acuity letter score (VALS), and number of treatments for macular edema. Retinas were classified as thin (≤216 µm), medium (>216 and ≤300 µm), or thick (>300 µm) based on CST.

Results

At Month 1, 15% (51/350) of retinas were thin, 57% (199/350) we

SUBMITTER: Scott IU 

PROVIDER: S-EPMC11402581 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature